|
  • sales@titanpharmaplus.in
  • Mon - Sat: 9:30 - 18:30

API Under Development

API Under Development

Products Under Validations

No. Product Name Grade Drug Category Status
1 Acotiamide IH Gastroprokinetic Agent Validations in Q1 26, Lab Samples Available
2 Finerenone IH Mineralocorticoid receptor Validations in Q1 26, Lab Samples Available
3 Minoxidil IP/EP/USP Antihypertensive/ Vasodilator Validations in Q4 25, Lab Samples Available
4 Sodium Fluoride IH/EP Dental Decay Validations in Q1 26, Lab Samples Available
5 Upadacitinib IH Antirheumatic (Janus Kinase Inhibitor) Validations in Q1 26, Lab Samples Available
6 Vonoprazan Fumarate IH Antiulcerant / GERD Treatment Validations in Q4 25, Lab Samples Available

Under Development

No. Product Name Grade Drug Category Status
1 Apalutamide IH Anti- Neoplastic Lab Samples by Q2 26
2 Avatrombopag IH Anti Thrombocytopenia Lab Samples by Q2 26
3 Cenobamate IH Anticonvulsant Lab Samples by Q1 26
4 Fezolinetant IH Women's Health Lab Samples by Q1 26
5 Pentoxifylline IP/EP/USP Antiplatelet Lab Samples by Q1 26
6 Resmetirom IH Treatment of NASH Lab Samples by Q4 25
7 Tofacitinib IH Antirheumatic (Janus Kinase Inhibitor) Lab Samples by Q2 26
8 Vortioxetine HBr IH Antidepressant Lab Samples by Q4 25

Pipeline

No. Product Name Drug Category
1 Belumosudil Chronic graft versus host disease (cGvHD) treatment
2 Cariprazine Anti-psychotic
3 Daridorexant Treatment of Insomnia
4 Elinzanetant Women's Health
5 Ferric Citrate Treatment of High Phosphate and Iron Deficiency
6 Fexuprazan Antiulcerant / GERD Treatment
7 Mirogablin Gabapentinoid for Neuropathic Pain
8 Ranolazine Treatment of chronic angina
9 Safinamide Anti Parkinson's
10 Sodium Zirconium Cyclosilicate Potassium Binder
11 Suzetrigine Pain Management
12 Tafamidis Transthyretin Amyloid Cardiomyopathy
13 Tenapanor Hcl Treatment of Irritable Bowel Syndrome
14 Venetoclax Anti Neoplastic
15 Xanomeline Tartrate Anti-psychotic

Titan Pharmaplus and it's associated companies respect the intellectual property rights of others. The listed products would be offered only in countries where the products do not constitute a patent infringement. However, research, experimental and developmental quantities may be offered for purpose of regulatory submission. Customer/Buyer should make their independent evaluation and would exclusively hold the final responsibility.